ADR News Bulletin 2018 May (Volume 20 Number 1)

Bulletin Highlights:

  • Gadolinium-based contrast agents and risk of gadolinium brain deposits
  • AE Case in Focus: Test Yourself
  • Risk of severe cutaneous adverse reactions with recombinant human erythropoeitins
  • Update on canagliflozin and risk of lower limb amputation
  • Caution on the use of lysozyme-containing products in patients with known egg allergy
  • Answers to AE Case in Focus: Test Yourself
  • List of Dear Healthcare Professional Letters
  • Non-steroidal anti-inflammatory drugs and cardiovascular risk - An update and reminder
  • Analysis of adverse event reports for year 2017 (bulletin insert)

Click on the link below to download the issue in pdf:

ADR_News_May2018_Vol20_No1

Analysis of AE reports for Year 2017_May2018_Vol 20_No1

Healthcare professional, Industry member, Therapeutic Products
Published:

Adverse Drug Reaction News Bulletins

13 Nov 2019
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.